Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 1 safety and pharmacokinetics study registration with no results posted; it describes planned enrollment and design only, typical of early-stage clinical development.
This is a Phase 1 safety and tolerability study in early recruitment with no results posted; it is designed to evaluate dose-limiting toxicities and adverse events, not efficacy.
This is a Phase 1/2A open-label, non-randomized safety and tolerability study of an investigational agent; no results are reported in this registry record.
This is an active Phase 3 trial registration with no reported results; the study design and primary endpoint are specified but outcome data are not yet available.
This is a Phase 1 dose-escalation and dose-expansion trial registration with no results posted; it is a first-in-human safety and tolerability study designed to establish dosing, not efficacy.
This is a Phase 3 trial registration with no results posted; the study is active but not recruiting, and primary outcome data are not yet available in this registry record.